Advanced Search

Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2012 October;60(5) > Minerva Cardioangiologica 2012 October;60(5):491-505

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases

Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752

Frequency: Bi-Monthly

ISSN 0026-4725

Online ISSN 1827-1618

 

Minerva Cardioangiologica 2012 October;60(5):491-505

INTERVENTIONAL INNOVATIONS 

Left main and bifurcation stenting

Carrié D.

CHU Toulouse Rangueil, Toulouse, France

Coronary artery bypass graft (CABG) is considered as the gold standard treatment of unprotected left main coronary artery disease. Over the last 10 years, improvement in stent technology and operators experience explained the increased number of reports on the results of percutaneous coronary interventions for the treatment of left main (LM) coronary artery lesion particularly in the distal part of the trunk. Patient selection for bifurcation stenting is fundamental and directly impacts the clinical outcome. Many trials are conducted using bifurcated stenting technology. Further randomized trials must be conducted to precise the indications of both techniques (CABG-PCI) of revascularization in the treatment of LM disease.

language: English


FULL TEXT  REPRINTS

top of page